-BIOCHEMISTRY-
PREMIUM THESIS TOPICS

Since Its Almost Impossible or at least very difficult to change the thesis topics once its approved by institutional ethical committee. Its therefor important that you choose a good as well as easy to do thesis. There is no point in unnecessarily choosing a complex thesis topic and getting frustrated for the rest of your residency. You can discuss with me before choosing any thesis topic and i will advice you accordingly.

Biochemistry Thesis Topics LIPID METABOLISM

List of Biochemistry thesis topics to choose from. You can take our advice before selecting any thesis topics as once approved by ethical committee its difficult to change thesis topics later.

This page covers lipid metabolism thesis topics across conventional lipid profiles and dyslipidaemia, lipid ratios and atherogenic indices, apolipoproteins and lipoprotein(a), lipid abnormalities in endocrine, renal and hepatic disorders, and inflammatory, oxidative-stress and micronutrient correlates. The topics are intended for MD Biochemistry candidates and can generally be completed within one thesis period using routinely available patients, anthropometry and laboratory investigations. The list also supports candidates searching for lipid metabolism research topics, while a structured lipid biochemistry protocol or lipid biochemistry synopsis can be developed once the primary lipid endpoint, fasting requirements and analytical method are fixed.

Last reviewed and updated: August 2026

📌 Updated for 2026–2027 MD Biochemistry admissions

The list was reviewed for practical lipid measurements, calculated cardiovascular-risk indices, secondary causes of dyslipidaemia and common analytical limitations.

Most topics can be completed with total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, glucose, HbA1c and selected thyroid, renal, hepatic or inflammatory investigations.
Ultracentrifugation, lipidomics, particle-size analysis and specialised genetic testing are not required for the majority of these projects.
Publication potential is strongest where fasting status, lipid-lowering treatment, secondary dyslipidaemia and the method used to derive LDL cholesterol or other calculated indices are prespecified.

Generate a protocol from any topic below

Select Generate Protocol → beside any title and receive a submission-ready document built around that topic, containing all eighteen components:

Introduction / Synopsis
Research Question
Aim of the Study
Primary Objective
Secondary Objectives
Materials and Methods
Inclusion Criteria
Exclusion Criteria
Sample Size Calculation
Methodology
Statistical Analysis
Ethical Considerations
Review of Literature
References
Gantt Chart / Study Timeline
Patient Information Sheet
Consent Form
Data Collection Form

Already know your thesis title?

Skip the list and generate the full conventional lipid profile, lipoproteins and dyslipidemia protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Conventional Lipid Profile, Lipoproteins and Dyslipidemia

A cross-sectional study of serum total cholesterol, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum lipid profile in patients with type 2 diabetes mellitus and apparently healthy individuals.
An observational study of the association between serum triglycerides and glycated hemoglobin in patients with type 2 diabetes mellitus.
A cross-sectional study of low-density lipoprotein cholesterol and its association with glycemic control in patients with type 2 diabetes mellitus.
A comparative study of high-density lipoprotein cholesterol levels in patients with adequate and poor glycemic control.
A cross-sectional study of serum lipid profile and its association with duration of type 2 diabetes mellitus.
A comparative cross-sectional study of serum lipid profile in obese and non-obese patients with type 2 diabetes mellitus.
An observational study of the association between body mass index and serum lipid parameters in adults.
A cross-sectional study of serum triglycerides and their association with waist circumference in adults with central obesity.
A comparative study of lipid profile in normal-weight and obese adults.
A cross-sectional study of serum lipid profile and its association with components of metabolic syndrome.
A comparative cross-sectional study of lipid parameters in individuals with and without metabolic syndrome.
An observational study of the association between serum triglycerides and the number of metabolic syndrome components.
A cross-sectional study of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol levels in individuals with metabolic syndrome.
A comparative study of serum lipid profile in hypertensive and normotensive adults.
A cross-sectional study of serum triglycerides and their association with systolic and diastolic blood pressure.
A comparative cross-sectional study of serum lipid parameters in male and female adults with metabolic syndrome.
An observational study of the relationship between age and serum lipid profile in adults.
A cross-sectional study of lipid abnormalities in adults with a family history of premature cardiovascular disease.
A comparative study of serum lipid profile in individuals with and without a family history of dyslipidemia.
A cross-sectional study of fasting serum lipid profile in patients with primary hypothyroidism.
A comparative cross-sectional study of lipid parameters in patients with hypothyroidism and euthyroid individuals.
An observational study of the association between thyroid-stimulating hormone and low-density lipoprotein cholesterol in hypothyroidism.
A cross-sectional study of serum triglycerides and high-density lipoprotein cholesterol in women with polycystic ovary syndrome.
A comparative study of serum lipid profile in women with polycystic ovary syndrome and apparently healthy women.
A cross-sectional study of lipid profile and its association with body mass index in women with polycystic ovary syndrome.
A comparative cross-sectional study of lipid abnormalities in obese and non-obese women with polycystic ovary syndrome.
An observational study of the association between serum lipid parameters and insulin resistance in women with polycystic ovary syndrome.
A cross-sectional study of serum lipid profile in patients with non-alcoholic fatty liver disease.
A comparative cross-sectional study of serum lipid parameters in individuals with and without non-alcoholic fatty liver disease.

Lipid Ratios, Atherogenic Indices and Cardiovascular Risk Markers

A cross-sectional study of total cholesterol to high-density lipoprotein cholesterol ratio and its association with glycemic control in patients with type 2 diabetes mellitus.
A comparative study of total cholesterol to high-density lipoprotein cholesterol ratio in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in patients with metabolic syndrome.
A comparative cross-sectional study of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in individuals with and without metabolic syndrome.
An observational study of the association between low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and central obesity.
A cross-sectional study of triglyceride to high-density lipoprotein cholesterol ratio and its association with insulin resistance in adults.
A comparative study of triglyceride to high-density lipoprotein cholesterol ratio in obese and normal-weight adults.
A cross-sectional study of triglyceride to high-density lipoprotein cholesterol ratio in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of triglyceride to high-density lipoprotein cholesterol ratio in patients with adequate and poor glycemic control.
An observational study of the association between triglyceride to high-density lipoprotein cholesterol ratio and glycated hemoglobin.
A cross-sectional study of atherogenic index of plasma and its association with serum lipid parameters in adults.
A comparative study of atherogenic index of plasma in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of atherogenic index of plasma and its association with glycated hemoglobin in type 2 diabetes mellitus.
A comparative cross-sectional study of atherogenic index of plasma in individuals with and without metabolic syndrome.
An observational study of the association between atherogenic index of plasma and waist circumference in adults.
A cross-sectional study of atherogenic index of plasma and its association with the number of metabolic syndrome components.
A comparative study of atherogenic index of plasma in obese and non-obese adults.
A cross-sectional study of atherogenic index of plasma in hypertensive adults and its association with blood pressure.
A comparative cross-sectional study of atherogenic index of plasma in hypertensive and normotensive individuals.
An observational study of the association between atherogenic index of plasma and serum uric acid.
A cross-sectional study of non-high-density lipoprotein cholesterol and its association with glycemic control in type 2 diabetes mellitus.
A comparative study of non-high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus and apparently healthy controls.
A cross-sectional study of non-high-density lipoprotein cholesterol and its association with metabolic syndrome components.
A comparative cross-sectional study of non-high-density lipoprotein cholesterol in individuals with and without central obesity.
An observational study of the association between non-high-density lipoprotein cholesterol and insulin resistance in adults.
A cross-sectional study of calculated remnant cholesterol and its association with glycemic parameters in patients with type 2 diabetes mellitus.
A comparative study of calculated remnant cholesterol in individuals with and without metabolic syndrome.
A cross-sectional study of calculated remnant cholesterol and its association with central obesity.
A comparative cross-sectional study of conventional lipid profile and calculated atherogenic indices in adults with metabolic syndrome.
A cross-sectional study of lipid ratios, atherogenic index of plasma, non-high-density lipoprotein cholesterol, and remnant cholesterol as biochemical markers of cardiovascular risk in adults.

Apolipoproteins, Lipoprotein(a) and Advanced Lipid Parameters

A cross-sectional study of serum apolipoprotein A1 and apolipoprotein B levels in patients with type 2 diabetes mellitus.
A comparative study of serum apolipoprotein A1 and apolipoprotein B levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of apolipoprotein B to apolipoprotein A1 ratio and its association with glycated hemoglobin in type 2 diabetes mellitus.
A comparative cross-sectional study of apolipoprotein B to apolipoprotein A1 ratio in patients with adequate and poor glycemic control.
An observational study of the association between apolipoprotein B and low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus.
A cross-sectional study of apolipoprotein A1 and its association with high-density lipoprotein cholesterol in adults.
A comparative study of apolipoprotein B to apolipoprotein A1 ratio in individuals with and without metabolic syndrome.
A cross-sectional study of apolipoprotein B to apolipoprotein A1 ratio and its association with the number of metabolic syndrome components.
A comparative cross-sectional study of apolipoprotein profiles in obese and normal-weight adults.
An observational study of the association between apolipoprotein B and central obesity.
A cross-sectional study of serum lipoprotein(a) levels in patients with type 2 diabetes mellitus.
A comparative study of serum lipoprotein(a) levels in patients with type 2 diabetes mellitus and apparently healthy individuals.
A cross-sectional study of serum lipoprotein(a) and its association with glycated hemoglobin in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of serum lipoprotein(a) levels in patients with adequate and poor glycemic control.
An observational study of the association between serum lipoprotein(a) and conventional lipid parameters in type 2 diabetes mellitus.
A cross-sectional study of serum lipoprotein(a) levels in individuals with metabolic syndrome.
A comparative study of serum lipoprotein(a) in individuals with and without metabolic syndrome.
A cross-sectional study of serum lipoprotein(a) and its association with the number of metabolic syndrome components.
A comparative cross-sectional study of serum lipoprotein(a) levels in hypertensive and normotensive adults.
An observational study of the association between serum lipoprotein(a) and body mass index.
A cross-sectional study of apolipoprotein B and non-high-density lipoprotein cholesterol as biochemical indicators of atherogenic particle burden in type 2 diabetes mellitus.
A comparative study of apolipoprotein B and calculated low-density lipoprotein cholesterol in adults with dyslipidemia.
A cross-sectional study of apolipoprotein B to apolipoprotein A1 ratio and atherogenic index of plasma in individuals with metabolic syndrome.
A comparative cross-sectional study of apolipoprotein-based and conventional lipid risk markers in patients with type 2 diabetes mellitus.
An observational study of the association between apolipoprotein B to apolipoprotein A1 ratio and insulin resistance.
A cross-sectional study of serum lipoprotein(a), apolipoprotein B, and non-high-density lipoprotein cholesterol in individuals with central obesity.
A comparative study of serum lipoprotein(a) and apolipoprotein B in obese and non-obese adults.
A cross-sectional study of apolipoprotein B to apolipoprotein A1 ratio and its association with serum uric acid.
A comparative cross-sectional study of serum apolipoproteins in individuals with metabolic syndrome with and without type 2 diabetes mellitus.
An observational study of the relationship between advanced lipid markers and conventional lipid profile in adults at increased cardiometabolic risk.

Lipid Metabolism in Endocrine, Renal, Hepatic and Other Clinical Disorders

A cross-sectional study of serum lipid profile and its association with thyroid-stimulating hormone in patients with primary hypothyroidism.
A comparative study of serum lipid parameters in subclinical hypothyroidism and euthyroid individuals.
A cross-sectional study of atherogenic lipid indices and their association with thyroid function parameters in hypothyroidism.
A comparative cross-sectional study of non-high-density lipoprotein cholesterol in individuals with subclinical hypothyroidism and euthyroid controls.
An observational study of the association between low-density lipoprotein cholesterol and severity of thyroid dysfunction.
A cross-sectional study of serum triglycerides and atherogenic index of plasma in women with polycystic ovary syndrome.
A comparative study of atherogenic lipid indices in women with polycystic ovary syndrome and apparently healthy women.
A cross-sectional study of non-high-density lipoprotein cholesterol and its association with insulin resistance in women with polycystic ovary syndrome.
A comparative cross-sectional study of lipid ratios in obese and non-obese women with polycystic ovary syndrome.
An observational study of the association between lipid abnormalities and serum androgen levels in women with polycystic ovary syndrome.
A cross-sectional study of serum lipid profile and its association with estimated glomerular filtration rate in patients with chronic kidney disease.
A comparative study of serum lipid profile across different stages of chronic kidney disease.
A cross-sectional study of atherogenic index of plasma and its association with severity of chronic kidney disease.
A comparative cross-sectional study of non-high-density lipoprotein cholesterol in patients with chronic kidney disease and apparently healthy individuals.
An observational study of the association between serum triglycerides and proteinuria in patients with chronic kidney disease.
A cross-sectional study of calculated remnant cholesterol and renal function parameters in chronic kidney disease.
A comparative study of lipid profile in diabetic and non-diabetic patients with chronic kidney disease.
A cross-sectional study of serum lipoprotein(a) and its association with estimated glomerular filtration rate in chronic kidney disease.
A comparative cross-sectional study of atherogenic lipid indices in patients with chronic kidney disease with and without diabetes mellitus.
An observational study of the association between dyslipidemia and serum uric acid in chronic kidney disease.
A cross-sectional study of serum lipid profile and liver enzyme levels in patients with non-alcoholic fatty liver disease.
A comparative study of serum lipid profile in individuals with and without non-alcoholic fatty liver disease.
A cross-sectional study of atherogenic index of plasma and its association with liver enzyme abnormalities in non-alcoholic fatty liver disease.
A comparative cross-sectional study of non-high-density lipoprotein cholesterol in individuals with and without fatty liver disease.
An observational study of the association between serum triglycerides and alanine aminotransferase in non-alcoholic fatty liver disease.
A cross-sectional study of triglyceride-glucose index and lipid profile in patients with non-alcoholic fatty liver disease.
A comparative study of atherogenic lipid indices in obese individuals with and without non-alcoholic fatty liver disease.
A cross-sectional study of serum lipid profile and albumin levels in patients with nephrotic syndrome.
A comparative cross-sectional study of lipid abnormalities in patients with nephrotic syndrome and apparently healthy individuals.
An observational study of the association between serum cholesterol and degree of hypoalbuminemia in patients with nephrotic syndrome.

Lipid Metabolism, Inflammation, Oxidative Stress, Micronutrients and Novel Metabolic Correlates

A cross-sectional study of high-sensitivity C-reactive protein and its association with serum lipid profile in patients with type 2 diabetes mellitus.
A comparative study of high-sensitivity C-reactive protein and lipid parameters in individuals with and without metabolic syndrome.
A cross-sectional study of high-sensitivity C-reactive protein and atherogenic index of plasma in adults with central obesity.
A comparative cross-sectional study of inflammatory markers and lipid ratios in obese and normal-weight adults.
An observational study of the association between high-sensitivity C-reactive protein and non-high-density lipoprotein cholesterol.
A cross-sectional study of serum ferritin and its association with serum lipid profile in patients with type 2 diabetes mellitus.
A comparative study of serum ferritin and atherogenic lipid parameters in individuals with and without metabolic syndrome.
A cross-sectional study of serum ferritin and triglyceride to high-density lipoprotein cholesterol ratio in adults.
A comparative cross-sectional study of serum ferritin levels in individuals with normal and elevated atherogenic index of plasma.
An observational study of the association between serum ferritin and non-high-density lipoprotein cholesterol.
A cross-sectional study of serum malondialdehyde and its association with serum lipid parameters in patients with type 2 diabetes mellitus.
A comparative study of serum malondialdehyde levels in individuals with and without dyslipidemia.
A cross-sectional study of total antioxidant capacity and its association with atherogenic lipid indices in adults.
A comparative cross-sectional study of oxidative stress markers in individuals with normal and abnormal lipid profiles.
An observational study of the association between oxidative stress and serum triglycerides in adults with metabolic syndrome.
A cross-sectional study of serum vitamin D levels and their association with serum lipid profile in adults.
A comparative study of lipid parameters in adults with vitamin D deficiency and vitamin D sufficiency.
A cross-sectional study of serum vitamin D and atherogenic index of plasma in patients with type 2 diabetes mellitus.
A comparative cross-sectional study of non-high-density lipoprotein cholesterol in individuals with deficient and sufficient vitamin D status.
An observational study of the association between serum vitamin D and high-density lipoprotein cholesterol.
A cross-sectional study of serum magnesium and its association with lipid profile in patients with metabolic syndrome.
A comparative study of serum magnesium levels in adults with and without dyslipidemia.
A cross-sectional study of serum zinc and copper-to-zinc ratio and their association with serum lipid parameters.
A comparative cross-sectional study of serum zinc levels in individuals with normal and abnormal lipid profiles.
An observational study of the association between copper-to-zinc ratio and atherogenic lipid indices.
A cross-sectional study of serum uric acid and its association with triglycerides and high-density lipoprotein cholesterol in adults.
A comparative study of serum uric acid levels in individuals with and without atherogenic dyslipidemia.
A cross-sectional study of triglyceride-glucose index and its association with atherogenic lipid parameters in adults.
A comparative cross-sectional study of triglyceride-glucose index, atherogenic index of plasma, and non-high-density lipoprotein cholesterol in individuals with and without metabolic syndrome.
A cross-sectional study of serum lipoprotein(a), apolipoprotein B, high-sensitivity C-reactive protein, oxidative stress markers, and conventional lipid parameters as biochemical correlates of cardiometabolic risk in adults.

Alongside conventional lipid profile, lipoproteins and dyslipidemia protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Conventional lipid profile, lipoproteins and dyslipidemia research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the conventional lipid profile, lipoproteins and dyslipidemia research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the conventional lipid profile, lipoproteins and dyslipidemia research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a conventional lipid profile, lipoproteins and dyslipidemia research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — QCHP and Hamad Medical Corporation. A conventional lipid profile, lipoproteins and dyslipidemia IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning conventional lipid profile, lipoproteins and dyslipidemia research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the conventional lipid profile, lipoproteins and dyslipidemia research proposal is the document assessed at the start of it.

Kuwait — KIMS. A conventional lipid profile, lipoproteins and dyslipidemia study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the conventional lipid profile, lipoproteins and dyslipidemia proposal follows the same structure throughout.

Generate a conventional lipid profile, lipoproteins and dyslipidemia research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A conventional lipid profile, lipoproteins and dyslipidemia dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full conventional lipid profile, lipoproteins and dyslipidemia research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

These are written individually, by a medical doctor, with no artificial intelligence generation and no plagiarism, and revised until the supervisor accepts them.

Enquire about a conventional lipid profile, lipoproteins and dyslipidemia PhD or MMed proposal →

🔥 Trending research areas in lipid metabolism for 2026–27

Apolipoprotein B and non-HDL cholesterol: these measures are increasingly studied as indicators of atherogenic particle burden when conventional LDL cholesterol alone may be insufficient.
Remnant cholesterol and atherogenic indices: calculated measures offer feasible research endpoints using routine lipid data, particularly in diabetes and metabolic syndrome.
Lipoprotein(a): its largely genetically determined concentration makes it an important cardiovascular-risk marker, but also creates specific problems when studying associations with short-term metabolic control.
Inflammatory and metabolic lipid phenotypes: hs-CRP, insulin resistance, oxidative stress and micronutrients are being studied alongside lipid parameters, with obesity and secondary dyslipidaemia requiring careful control.

Protocol and synopsis guidance

What a lipid metabolism protocol must contain

Define exactly how every lipid endpoint is obtained. The protocol should distinguish directly measured values from calculated values. LDL cholesterol may be measured directly or estimated by an equation, while non-HDL cholesterol, remnant cholesterol, lipid ratios and the atherogenic index of plasma are derived variables. The equation, units and handling of extreme triglyceride concentrations should be prespecified.

Record treatment and secondary causes before interpreting dyslipidaemia. Statins, fibrates and other lipid-modifying drugs can substantially alter the outcome. Diabetes, hypothyroidism, nephrotic syndrome, chronic kidney disease, liver disease, obesity and alcohol exposure can also change the lipid profile. These variables should be part of the eligibility criteria or analytical plan rather than discovered after group comparisons are made.

Standardise pre-analytical conditions. Triglycerides are particularly sensitive to recent food intake and can influence several calculated indices. The protocol should define fasting requirements where relevant, sample timing, specimen handling and the laboratory platform so that differences between groups are not created by inconsistent sampling.

Lipid metabolism synopsis versus lipid metabolism protocol

A synopsis is the concise academic plan submitted for departmental or university approval, whereas the protocol is the operational document used to conduct the study. For lipid metabolism research, the protocol should specify fasting status, lipid-lowering therapy, assay platform, whether LDL cholesterol is direct or calculated, the formulae for lipid ratios and derived indices, and the secondary causes of dyslipidaemia that will be excluded or adjusted for.

The distinction matters because two studies labelled as lipid-profile comparisons may not be methodologically equivalent. A calculated LDL cholesterol value can behave differently when triglycerides are high, and a derived variable such as remnant cholesterol may share components with the lipid measurements against which it is correlated. The protocol must identify these dependencies before analysis.

Sample size and statistical analysis

Calculate sample size from the primary lipid outcome. Comparative studies require an expected difference and variability for the selected lipid parameter, while correlation studies require an anticipated correlation coefficient. A project measuring many lipid ratios should still nominate one primary endpoint rather than choosing the most significant result after analysis.

Avoid statistical circularity with derived indices. Correlating an index with a variable that is already part of its formula can produce an association partly by construction. For example, triglyceride-based indices will naturally relate to triglycerides. The protocol should distinguish mathematically coupled comparisons from clinically independent associations.

Expect skewed distributions and major confounding. Triglycerides and lipoprotein(a) are often non-normally distributed. Appropriate transformation or non-parametric methods may be required. Age, sex, adiposity, diabetes, thyroid status, renal function, smoking and lipid-lowering treatment should be considered when they can affect both the exposure and lipid outcome.

Frequently Asked Questions – Conventional Lipid Profile, Lipoproteins And Dyslipidaemia (2026–27)

1. How do I choose a feasible lipid metabolism thesis topic in 2026?

Start with the lipid measurements reliably available in the laboratory and a patient population seen in sufficient numbers. Conventional lipid parameters and calculated indices are usually highly feasible, while apolipoproteins and lipoprotein(a) require confirmation of assay availability and cost. A strong topic has one primary lipid endpoint, clearly defined comparison groups and a plan for lipid-lowering treatment and secondary causes of dyslipidaemia.

2. Which study designs are accepted for lipid metabolism research?

Cross-sectional, comparative cross-sectional, case-control, cohort and retrospective record-based designs can all be appropriate. Cross-sectional studies suit associations between lipid parameters and metabolic variables, comparative designs suit predefined clinical groups, and cohort studies are preferable when the objective involves change after an exposure or over time. The study design should match the research question rather than the number of lipid tests performed.

3. What should I settle with my guide before starting the study?

Agree on the primary lipid endpoint, fasting requirements, assay method, method of LDL cholesterol estimation, formulae for calculated indices, comparison groups and the handling of lipid-lowering treatment. Also decide which secondary causes of dyslipidaemia, including diabetes, hypothyroidism, renal disease, nephrotic syndrome and liver disease, will be excluded, stratified or adjusted for.

4. Can calculated lipid indices be used as thesis outcomes?

Yes, provided the formula, units and rationale are stated before analysis. Non-HDL cholesterol, remnant cholesterol, triglyceride-to-HDL cholesterol ratio and atherogenic index of plasma can provide feasible research endpoints from routine laboratory data. However, derived indices are not independent of the measurements used to calculate them, so correlations with their own components should not be presented as if they were entirely separate biological relationships.

5. What is the difference between a lipid metabolism synopsis and a protocol?

The synopsis presents the research question, rationale, objectives and broad methodology for academic approval. The protocol contains the operational detail needed to reproduce the study, including fasting conditions, treatment exposure, assay methods, calculation formulae, eligibility criteria, secondary causes of dyslipidaemia and statistical analysis. These details determine whether observed lipid differences are biologically meaningful or method-dependent.

6. What ethical issues should I address in lipid metabolism studies?

Prospective studies involving children require guardian consent and, from about seven years where appropriate, child assent. Record-based studies may seek a waiver of consent when permitted by the ethics committee and when confidentiality safeguards are adequate. Research-only venepuncture should be minimised and any additional blood volume should be explicitly limited according to age and institutional policy. Extra radiation or contrast exposure is not justified for a purely biochemical lipid endpoint. Separate consent is required for identifiable photographs or video. The protocol should also state how clinically important incidental findings such as very high triglycerides, severe hypercholesterolaemia or a lipid pattern suggesting familial dyslipidaemia will be communicated for clinical assessment.

7. Why can calculated LDL cholesterol be misleading in a lipid metabolism study?

Calculated LDL cholesterol depends on the equation used and on the concentrations of other lipid components. Accuracy can deteriorate in samples with high triglycerides or very low LDL cholesterol, and different equations may classify the same participant differently. A protocol should therefore name the equation, define when calculated LDL cholesterol will not be used, and state whether direct LDL measurement is available for problematic samples. Mixing direct and calculated LDL values without a prespecified rule can introduce avoidable measurement heterogeneity.

8. How is a PhD proposal different from an MD Biochemistry synopsis?

An MD synopsis is usually centred on a focused clinical-biochemical question that can be completed during postgraduate training using available patients and laboratory facilities. A PhD proposal generally requires a broader and more original programme of investigation, potentially involving advanced lipid phenotyping, mechanistic work, longitudinal follow-up or multiple linked objectives. The expected novelty, depth and duration are therefore different.

9. When should I register my lipid metabolism thesis topic?

Registration should follow confirmation that the required patient population, lipid assays, treatment information and laboratory methods are available. It should be completed early enough to allow protocol approval and standardised sampling before substantial data collection begins, particularly when fasting conditions or specialised lipid measurements are required.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.